Stay updated with breaking news from Cure trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rhenman & Partners Asset Management AB bought a new position in NovoCure Limited (NASDAQ:NVCR – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 160,000 shares of the medical equipment provider’s stock, valued at approximately $2,389,000. Rhenman & Partners Asset Management AB […] ....
Rhenman & Partners Asset Management AB bought a new position in NovoCure Limited (NASDAQ:NVCR – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 160,000 shares of the medical equipment provider’s stock, valued at approximately $2,389,000. Rhenman & Partners Asset Management AB […] ....
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 90,500 shares, a drop of 19.5% from the April 30th total of 112,400 shares. Based on an average daily volume of 287,500 shares, the […] ....
AtriCure (NASDAQ:ATRC – Free Report) had its target price trimmed by Needham & Company LLC from $46.00 to $40.00 in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the medical device company’s stock. Several other brokerages also recently commented on ATRC. StockNews.com downgraded shares of […] ....
AtriCure (NASDAQ:ATRC) Stock Price Down 5.5% After Insider Selling theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.